Type 1 diabetes (T1D) is an autoimmune disease resulting from the damage of pancreatic -cells mediated by autoreactive CD4 + and CD8 + T cells. In recent years, follicular T helper (Tfh) cells have been recognized as a subpopulation of CD4 + T cells providing help for B cells differentiation and antibody production. In this study, we examined the frequency of circulating CD4 + CXCR5 + and CD4 + CXCR5 + ICOS + (representing Tfh) cells as well as serum levels of anti-glutamic acid decarboxylase 65 (GAD65) and islet cell autoantibodies (ICA) in children with type I diabetes.
INTRODUCTION
Type 1 diabetes (T1D) is a chronic autoimmune disease occurs following the destruction of pancreatic -cells mediated by T cells in genetically susceptible individuals. [1] [2] [3] The incidence of type 1 diabetes in children differs between countries ranging from 0.1 to 40.9 per 100,000 per year. Type1 diabetes can be diagnosed at any age, but it is often happened between birth and 14 years old. 4 Unlike most autoimmune disorders, T1D affects females and males equally. 5 Although autoreactive CD4+ and CD8+ T cells are main factors of β-cell destruction, B cells and autoantibodies may also play a critical role in T1D development and progression. 2 Bruton's tyrosine kinase deficient non-obese diabetic (Btk-NOD) mice showing antibody deficiency are protected from T1D. 6 In human, depletion of B-lymphocytes by anti-CD20 (rituximab) resulted in significant preservation of β-cell function in new onset of T1D. 7 Moreover, autoantibodies against islet antigens such as islet-cell cytoplasmic autoantibodies (ICA), glutamic acid decarboxylase antibodies (GADA) and zinc transporter 8 protein autoantibodies (ZnT8A), are strongly associated with development of the disease. These autoantibodies are also strong predictors of the later development of the disease. 8 In recent years, T follicular helper (Tfh) cells have been recognized as a subpopulation of CD4 + T cells that required for germinal center formation, B cells differentiation and antibody production. 9 Tfh cells express molecules such as B cell lymphoma 6 (Bcl-6) transcription factor, CXC-chemokine receptor 5 (CXCR5), programmed death-1 (PD-1), inducible costimulatory (ICOS), and interleukin 21 (IL-21) which are functionally important. 10 21 Moreover, a number of studies demonstrated higher level of Tfh cells in blood of adult T1D patients and its correlation with autoantibody production. [22] [23] [24] In the present research, we sought to investigate the frequency of Tfh cells and Anti-GAD65 autoantibodies and ICA in children with new-onset T1D.
MATERIALS AND METHODS

Patients and Controls
A total of 20 patients with T1D (11 girls and 9 boys; age: 7.5±0.9 years; range: 1-15 years) were enrolled in this study. The duration of the disease was 186.76±95.8 days (disease duration≤300 days from the onset). The diagnosis was based on the criteria of World Health Organization 25 and American Diabetes Association. 26 All the patients were referred to Shariati For measurement of autoantibodies levels, sera of patients and controls were separated and stored at -80°C until the day of test. Islet cells autoantibody (ICA) in sera of studied subjects were detected by indirect immunofluorescence assay according to the manufacture instruction (EUROIMMUNE, Germany). Briefly, frozen sections of monkey pancreas were incubated with diluted serum samples. In the next step, the attached antibodies were stained with FITC conjugated anti-human antibodies. The glass slides were analyzed by the fluorescence microscope and considered positive at a titer of ≥1:10.
Sera from T1D patients and healthy controls were tested for the presence of anti-GAD (glutamic acid decarboxylase) antibody using ELISA, according to the manufacturers' instructions (EUROIMMUNE, Germany). Microplate was coated by human recombinant glutamic acid decarboxylase, isoform GAD65. The lower detection limit of the anti-GAD ELISA was 0.2 IU/mL. Results were interpreted by a cut-off value recommended by EUROIMMUN as follows: < 10 IU/mL: Negative; ≥ 10 IU/mL: Positive.
Statistical Analyses
Statistical analyses were performed using SPSS Statistics, version 21 (SPSS Inc., Chicago, Ill., USA). Values were expressed as means±SD. The Shapiro-Wilk test was used as a test of normality. Statistical significance of Tfh frequency between groups was calculated by independent T test.
Chi-square test was used for analysis of GAD and Islet cells autoantibodies in T1D patients and healthy controls. We applied Pearson correlation test to obtain the association of Tfh frequency, the autoantibodies, disease duration and age. The p value less than 0.05 were considered significant. 
RESULTS
Increased
Anti-GAD and ICA Autoantibodies in T1D Patients
In this study, we examined the serum level of these autoantibodies in patients and controls. Our data revealed higher frequency of anti-GAD and ICA positive cases in T1D patients compared to controls (45% vs 0%; p=0.001 and 80% vs 38.8%; p=0.02 respectively) ( Table 1) . 
Circulating Tfh Cells Is not Associated with Autoantibodies Levels and Disease Duration
In this study, we also investigated potential correlation between CD4 + CXCR5 + ICOS + T cells frequency and anti-GAD and ICA in T1D patients. Our results indicated that there was no relationship between Tfh cells percentage and the level of anti-GAD autoantibodies, ICA and disease duration (p> 0.05). We also compared Tfh cells between anti-GAD and ICA positive and negative patients. There was no significant difference between the groups.
DISCUSSION
In the present study, we showed that circulating CXCR5 Type1 diabetes is characterized by the presence of circulating autoantibodies to a variety of islet cell antigens including GAD and ICA. 29 These autoantibodies are strongly associated with development of the disease and serve to diagnose and predict the later development of T1D. 8 However, the antibody titer levels might be decrease as the disease progresses. 29 In our study eighty percent of patients were ICA positive while 45% of patients were anti-GAD positive. Consistent with our result, ICA are observed in 70% to 80% of individuals with new-onset T1D and positivity decrease after the diagnosis of the disease. About 5% of patients are ICA positive after 10 years. 8 Furthermore, approximately 38% of healthy controls were also positive for ICA. Nondiabetic ICA positive individuals are susceptible for the development of T1D and ICA is used for selection of high risk subjects. 30 In agreement with previous studies, we did not observe significant correlations between autoantibody levels and frequencies of circulating Tfh cells. Our data support the idea that increased frequency of circulating Tfh cells may be associated with the development of T1D in children and manipulation of these cells could be considered as a therapeutic target.
